Modulating the VIP-VIPR pathway reprograms CAR T cells for superior antitumor efficacy in preclinical cancer models Posted on July 24, 2026 by admin
Development of a Novel Armored CAR-T Immunotherapeutic for Pancreatic Cancer Posted on May 30, 2025May 30, 2025 by admin
Development of a Novel Immunotherapeutic for Acute Myeloid Leukemia Posted on June 12, 2024May 12, 2025 by admin
